thanks for this great work. the bottom line would seem to be, that these results are strong enough that a sophisticated partner jumps on board to take us the rest of the way - i assume setting up a new trial with a larger patient population.

it's still interesting to me that we apparently "hit it out of the park" with these results, and yet there is no communication along those lines to shareholders.
rather, we're left to interpret it on our own. i guess it is what it is, but we've been waiting on this for so long (before the end of last year), that i'm just puzzled.

Decent chance that we get some big news this shortened week? I think so. My money is on a new CEO - which i think would be huge for us.